GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taro Pharmaceutical Industries Ltd (NYSE:TARO) » Definitions » FCF Margin %

Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) FCF Margin % : -2.26% (As of Dec. 2023)


View and export this data going back to 1987. Start your Free Trial

What is Taro Pharmaceutical Industries FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Taro Pharmaceutical Industries's Free Cash Flow for the three months ended in Dec. 2023 was $-3.6 Mil. Taro Pharmaceutical Industries's Revenue for the three months ended in Dec. 2023 was $157.1 Mil. Therefore, Taro Pharmaceutical Industries's FCF Margin % for the quarter that ended in Dec. 2023 was -2.26%.

As of today, Taro Pharmaceutical Industries's current FCF Yield % is 5.39%.

The historical rank and industry rank for Taro Pharmaceutical Industries's FCF Margin % or its related term are showing as below:

TARO' s FCF Margin % Range Over the Past 10 Years
Min: -48.1   Med: 41.63   Max: 45.68
Current: 14.08


During the past 13 years, the highest FCF Margin % of Taro Pharmaceutical Industries was 45.68%. The lowest was -48.10%. And the median was 41.63%.

TARO's FCF Margin % is ranked better than
82.94% of 1026 companies
in the Drug Manufacturers industry
Industry Median: -0.675 vs TARO: 14.08


Taro Pharmaceutical Industries FCF Margin % Historical Data

The historical data trend for Taro Pharmaceutical Industries's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taro Pharmaceutical Industries FCF Margin % Chart

Taro Pharmaceutical Industries Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.74 37.72 5.21 -48.10 2.08

Taro Pharmaceutical Industries Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.57 32.82 0.59 27.33 -2.26

Competitive Comparison of Taro Pharmaceutical Industries's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Taro Pharmaceutical Industries's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taro Pharmaceutical Industries's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Taro Pharmaceutical Industries's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Taro Pharmaceutical Industries's FCF Margin % falls into.



Taro Pharmaceutical Industries FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Taro Pharmaceutical Industries's FCF Margin for the fiscal year that ended in Mar. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2023 )/Revenue (A: Mar. 2023 )
=11.903/572.952
=2.08 %

Taro Pharmaceutical Industries's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-3.553/157.145
=-2.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Taro Pharmaceutical Industries FCF Margin % Related Terms

Thank you for viewing the detailed overview of Taro Pharmaceutical Industries's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Business Description

Traded in Other Exchanges
Address
14 Hakitor Street, P.O. Box 10347, Haifa Bay, Haifa, ISR, 2624761
Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.
Executives
Sun Pharma Global Inc 10 percent owner
Sun Pharmaceutical Industries Ltd 10 percent owner, other: Affiliated Party 17/B, MAHAL INDUSTRIAL ESTATE, MAHAKALI CAVES ROAD, ANDEHERI (EAST) K7 400 093
Alkaloida Chemical Co Exclusive Group Ltd. 10 percent owner KABAY JANOS UT 29., TISZAVASVARI K5 4440
Franklin Resources Inc 10 percent owner FRANKLIN RESOURCES INC, ONE FRANKLIN PARKWAY, SAN MATEO CA 94403

Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Headlines